An official website of the United States government
Home
Name
DC Vax Injection
Alternate Names
DCVax- L
DCVaz (R)-l
Abbreviations
None
Category
Other therapy
Subcategory
None
NSC Number
None
Primary Site
Brain
Histology
Glioblastoma Multiforme
Remarks
DC Vax is dendrtitic cell immunotherapy. It is a personalized vaccine. As of August 2015, DC Vax is still in Phase III clinical trials and has not yet received FDA approval. Code as Other Treatment (assign code 2).
Coding
Please see remarks for additional information
